Pharmacy Times
JULY 16, 2025
Importantly, ACIP’s recommendations do have a strong influence, if not a mandate, on health insurance companies with respect to coverage and co-payments for immunizations as well as the Vaccines for Children Program, which provides coverage for access to vaccines for those who are 18 years or younger.
Pharmacy Times
JULY 25, 2025
First-generation oral cephalosporins (ie, cephalexin and cefadroxil) have excellent coverage of methicillin-susceptible S aureus and Streptococcus spp, making them ideal agents for treatment. Typically, empiric coverage for UTIs includes Escherichia coli and Klebsiella pneumoniae.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Beckers Hospital Review
AUGUST 1, 2025
Mr. Angelone, co-founder and chief commercial officer of MacroHealth, has over 25 years of experience in the health insurance and technology industries. Mr. Angelone has also ensured compliance with key regulations like the No Surprises Act and Transparency in Coverage rules, promoting greater transparency in healthcare pricing.
Putting Patients First Blog
JANUARY 10, 2024
Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Novo Nordisk is another company leading the charge in this field.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Novo Nordisk is another company leading the charge in this field.
Putting Patients First Blog
MARCH 4, 2024
Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.
Expert insights. Personalized for you.
Let's personalize your content